March 13, 2015
The Pharmaceuticals and Medical Devices Agency (PMDA) plans to introduce a full-scale system for receiving reports of adverse drug reactions (ADRs) directly from patients by FY2018, the final year of its third midterm plan. A patient ADR reporting system was...read more